CN Stock MarketDetailed Quotes

300630 Hainan Poly Pharm

Watchlist
  • 14.47
  • -0.20-1.36%
Pre-Opening Auction Apr 29 09:30 CST
6.54BMarket Cap17.69P/E (TTM)

Hainan Poly Pharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hainan Poly Pharm Earnings Date

Currency: CNY

Period

Q3 FY2023 Earnings

--

Revenue(YoY)

518.19M

-9.89%
Net Income(YoY)

134.35M

-19.96%
Analyst Rating

Buy

Apr 28, 2024

Hainan Poly Pharm Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/FY-- / 2.377B--
--2023/FY-- / 2.051B--
--2022/FY1.806B / 1.983B--
--2021/FY1.509B / 1.693B--
--2020/FY1.189B / 1.223B--
--2019/FY950.095M / 1.100B--
DatePeriodRevenue/EstimateEarnings Call
--2024/FY-- / 2.377B--
--2023/FY-- / 2.051B--
--2022/FY1.806B / 1.983B--
--2021/FY1.509B / 1.693B--
--2020/FY1.189B / 1.223B--
--2019/FY950.095M / 1.100B--
--------
--------
--------
--------

Unlock Free Earnings Estimates

Hainan Poly Pharm Earnings Reports

  • Pulley Pharmaceuticals: Report for the Third Quarter of 2023

    Oct 24, 2023 12:00 ET

  • Puli Pharmaceuticals: Summary of the 2023 Semi-Annual Report

    Aug 24, 2023 12:00 ET

  • Puli Pharmaceuticals: Semi-Annual Report 2023

    Aug 24, 2023 12:00 ET

  • Pulley Pharmaceuticals: First Quarter 2023 Report (Updated)

    Apr 25, 2023 07:58 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Buy

    • Strong Buy

      25.00%

    • Buy

      75.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg